Akari Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

• click to rate

  Posted by Two Blokes May 15 - Filed in Stock - 2 views
  
  Advancing development of novel Antibody Drug Conjugates (ADCs) with immuno-oncology payloads to treat multiple cancer tumors